focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,978.00
Bid: 1,983.00
Ask: 1,984.00
Change: -5.00 (-0.25%)
Spread: 1.00 (0.05%)
Open: 1,983.00
High: 1,991.00
Low: 1,971.00
Prev. Close: 1,983.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

BROKER RATINGS SUMMARY: Barclays Reviews Banks, Goldman Property Firms

Thu, 15th Mar 2018 09:53

LONDON (Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:----------FTSE 100----------BARCLAYS REINITIATES HSBC WITH 'EQUAL WEIGHT' - PRICE TARGET 700 PENCE----------BARCLAYS RESUMES STANDARD CHARTERED WITH 'UNDERWEIGHT' - TARGET 685 PENCE----------BARCLAYS RESUMES RBS WITH 'OVERWEIGHT' - TARGET 310 PENCE----------BARCLAYS REINITIATES LLOYDS BANKING WITH 'OVERWEIGHT' - TARGET 90 PENCE----------BARCLAYS CUTS SCHRODERS PRICE TARGET TO 3340 (3380) PENCE - 'UNDERWEIGHT'----------JPMORGAN RAISES PRUDENTIAL PRICE TARGET TO 1899 (1800) PENCE - 'NEUTRAL'----------CFRA RAISES PRUDENTIAL TO 'BUY' (HOLD) - PRICE TARGET 2100 (1900) PENCE----------DEUTSCHE BANK RAISES ANTOFAGASTA TO 'HOLD' ('SELL') - TARGET 1000 (900) PENCE----------CREDIT SUISS RAISES ANTOFAGASTA PRICE TARGET TO 800 (780) PENCE - 'UNDERPERFORM'----------GOLDMAN SACHS RAISES SEGRO PRICE TARGET TO 620 (585) PENCE - 'NEUTRAL'----------CREDIT SUISSE CUTS HAMMERSON TO 'NEUTRAL' ('OUTPERFORM') - TARGET 460 (605) PENCE----------GOLDMAN RAISES HAMMERSON TO 'CONVICTION BUY LIST' ('BUY') - TARGET 620 (625) PENCE----------GOLDMAN CUTS BRITISH LAND CO PRICE TARGET TO 650 (660) PENCE - 'NEUTRAL'----------GOLDMAN CUTS LAND SECURITIES TO 'SELL' ('NEUTRAL') - TARGET 865 (1055) PENCE----------GOLDMAN RAISES WM MORRISON SUPERMARKETS PRICE TARGET TO 216 (212) PENCE - 'NEUTRAL'----------GOLDMAN CUTS IMPERIAL BRANDS TO 'NEUTRAL' ('CONVICTION BUY LIST') - PRICE TARGET 2760 (3610) PENCE----------FTSE 250----------CITIGROUP CUTS INMARSAT PRICE TARGET TO 430 (530) PENCE - 'NEUTRAL'----------UBS RAISES BALFOUR BEATTY PRICE TARGET TO 330 (315) PENCE - 'BUY'----------UBS RAISES COMPUTACENTER TO 'BUY' ('NEUTRAL') - TARGET 1230 (1150) PENCE----------JPMORGEN RAISES HIKMA PHARMACEUTICAL PRICE TARGET TO 1050 (1000) PENCE - 'NEUTRAL'----------CITIGROUP RAISES HIKMA PHARMACEUTICALS TO 'BUY' - TARGET 1250 PENCE----------JEFFERIES RAISES HIKMA PHARMACEUTICALS TO HOLD (UNDERPERFORM) - TARGET 997 (895) PENCE----------DEUTSCHE BANK CUTS KAZ MINERALS TO 'SELL' ('HOLD') - TARGET 800 PENCE----------SOCGEN CUTS GREENCORE PRICE TARGET TO 190 (245) PENCE - 'BUY'----------NUMIS CUTS GREENCORE TO 'HOLD' ('BUY') - TARGET 138 (275) PENCE----------BARCLAYS CUTS GREENCORE PRICE TARGET TO 180 (253) PENCE - 'OVERWEIGHT'----------GOLDMAN CUTS SHAFTESBURY PRICE TARGET TO 835 (890) PENCE - 'SELL'----------GOLDMAN CUTS INTU PROPERTIES PRICE TARGET TO 260 (270) PENCE - 'BUY'----------CREDIT SUISSE CUTS INTU PROPERTIES TO 'UNDERPERFORM' ('OUTPERFORM') - TARGET 205 (270) P----------GOLDMAN CUTS GREAT PORTLAND PRICE TARGET TO 665 (675) PENCE - 'NEUTRAL'----------GOLDMAN CUTS DERWENT LONDON PRICE TARGET TO 3025 (3050) PENCE - 'NEUTRAL'----------GOLDMAN CUTS BIG YELLOW GROUP TO 'NEUTRAL' ('BUY')----------BERENBERG RAISES SENIOR PRICE TARGET TO 336 (310) PENCE - 'BUY'----------GOLDMAN CUTS ROTORK PRICE TARGET TO 275 (280) PENCE - 'NEUTRAL'----------BARCLAYS CUTS MCCARTHY & STONE PRICE TARGET TO 136 (144) PENCE - 'UNDERWEIGHT'----------MAIN MARKET AND AIM----------LIBERUM CUTS TYMAN PRICE TARGET TO 385 (410) PENCE - 'BUY'----------LIBERUM RAISES CHARLES TAYLOR PRICE TARGET TO 330 (327) PENCE - 'BUY'----------PEEL HUNT INITIATES ACCESSO TECHNOLOGY WITH 'BUY' - TARGET 3100 PENCE----------GOLDMAN RAISES SECURE INCOME REIT PRICE TARGET TO 460 (430) PENCE - 'BUY'----------JPMORGAN RAISES ABCAM PRICE TARGET TO 1011 (946) PENCE - 'NEUTRAL'----------Peel Hunt Puts Sportech Rating Under Review From Buy----------Peel Hunt Moves Frontier Smart Technologies To Add From Under Review----------

More News
3 Jan 2023 09:25

Hikma launches version of Xyrem medicine in US for treating narcolepsy

(Alliance News) - Hikma Pharmaceuticals PLC on Tuesday said it launched an authorised generic version of the Xyrem sodium oxybate prescription medicine in the US for treating narcolepsy.

Read more
3 Jan 2023 09:24

LONDON BROKER RATINGS: Citigroup cuts Wizz Air; Redburn likes CRH

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning, Monday and late Friday:

Read more
3 Jan 2023 09:03

LONDON MARKET OPEN: Stocks jump in first session of 2023

(Alliance News) - Stock prices in London made a strong start to the new year on Tuesday, despite weak Chinese data and the UK suffering a fresh wave of rail strikes.

Read more
3 Jan 2023 07:58

LONDON BRIEFING: Stocks called higher; China factory sector shrinks

(Alliance News) - Stocks in London are expected to start a new year on the front foot on Tuesday, after a mixed session in Asia amid weak Chinese economic data.

Read more
3 Jan 2023 07:46

Hikma launches generic narcolepsy solution in US

(Sharecast News) - Hikma Pharmaceuticals has launched an authorised generic version of Jazz Pharmaceuticals' 'Xyrem 1', or sodium oxybate oral solution, it announced on Tuesday.

Read more
8 Dec 2022 09:48

LONDON BROKER RATINGS: JPMorgan cuts Travis Perkins; BofA likes IAG

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

Read more
6 Dec 2022 10:48

RBC Capital Markets starts Hikma at 'outperform'

(Sharecast News) - RBC Capital Markets initiated coverage of Hikma Pharmaceuticals on Tuesday at 'outperform' with a 1,750p price target.

Read more
6 Dec 2022 10:26

LONDON BROKER RATINGS: JPMorgan cuts Lloyds but raises Barclays

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
15 Nov 2022 12:10

Credit Suisse initiates coverage of Hikma at 'outperform'

(Sharecast News) - Credit Suisse has initiated coverage of Hikma Pharmaceuticals with an 'outperform' rating.

Read more
15 Nov 2022 09:58

LONDON BROKER RATINGS: Jefferies cuts Aston Martin to 'underperform'

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
14 Nov 2022 09:25

LONDON BROKER RATINGS: Credit Suisse cuts Ferrexpo to 'neutral'

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
8 Nov 2022 09:39

LONDON BROKER RATINGS: Peel cuts Persimmon; Liberum raises Hammerson

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
3 Nov 2022 11:17

Hikma Pharmaceuticals reiterates 2022 guidance as costs widen

(Alliance News) - Hikma Pharmaceuticals PLC on Thursday reiterated annual guidance for all three of its businesses, continuing to expect them to underperform against 2021 due to rising costs.

Read more
3 Nov 2022 11:08

With tighter purse strings, is parity less probable for the pound?

STOXX 600 down 1.1%

*

Read more
3 Nov 2022 09:28

Banks, insurance dodge carnage as real estate stocks sink

Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at .

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.